Table 1.
Demography of study patients
| Group | NBNC | AILD | CHB | CHC | Multiple comparison | ||||
|---|---|---|---|---|---|---|---|---|---|
| Total | (n=153) | (Percentage or SD) | (n=33) | (Percentage or SD) | (n=261) | (Percentage or SD) | (n=63) | (Percentage or SD) | |
| Male | 90 | 58.8% | 6 | 18.2% | 196 | 75.1% | 37 | 58.7% | CHB≠(NBNC=CHC)≠AILD |
| HCC | 5 | 3.3% | 0 | 0.0% | 62 | 23.8% | 6 | 9.5% | CHB≠(NBNC=AILD) |
| Fat cell fraction >5% | 127 | 83.0% | 7 | 21.2% | 145 | 55.6% | 31 | 49.2% | NBNC≠AILD≠(CHB=CHC) |
| Age (year) | 47.81 | ±11.71 | 53.99 | ±13.73 | 51.35 | ±11.06 | 52.47 | ±11.05 | NBNC≠(AILD=CHB=CHC) |
| Bilirubin (mg/dL) | 0.82 | ±0.61 | 1.43 | ±1.07 | 0.94 | ±1.37 | 0.79 | ±0.24 | AILD≠(NBNC=CHC) |
| AST (U/L) | 58.09 | ±31.26 | 94.41 | ±52.50 | 50.17 | ±41.63 | 54.73 | ±39.64 | AILD≠(NBNC=CHB=CHC) |
| ALT (U/L) | 98.17 | ±44.94 | 90.94 | ±41.06 | 60.34 | ±40.35 | 63.93 | ±49.91 | AILD≠(CHB=CHC); NBNC≠CHB |
| ALP (U/L) | 83.54 | ±49.76 | 267.85 | ±186.79 | 77.55 | ±35.49 | 81.05 | ±26.91 | AILD≠(NBNC=CHB=CHC) |
| GGT (U/L) | 104.64 | ±194.33 | 468.40 | ±447.37 | 44.94 | ±47.85 | 59.0 | ±47.92 | AILD≠(CHB=CHC); NBNC≠CHB |
| PLT (109/L) | 226.45 | ±68.31 | 250.23 | ±120.31 | 184.73 | ±57.44 | 186.48 | ±61.05 | AILD≠(CHB=CHC); NBNC≠CHB |
| INR | 1.04 | ±0.09 | 1.03 | ±0.10 | 1.07 | ±0.09 | 1.07 | ±0.08 | NBNC≠(CHB=CHC) |
| BMI | 26.80 | ±4.48 | 24.01 | ±3.66 | 25.11 | ±3.9 | 25.67 | ±3.84 | NBNC≠(AILD=CHB) |
| Spleen index | 16.77 | ±6.46 | 21.49 | ±11.39 | 15.82 | ±6.44 | 15.77 | ±6.15 | AILD≠(CHB=CHC=NBNC) |
| Fibrosis score 0 |
28 | 18.3% | 0 | 0.0% | 8 | 3.1% | 2 | 3.2% | NBNC≠(CHB=CHC=AILD) |
| 1 | 80 | 52.3% | 11 | 33.3% | 50 | 19.23% | 21 | 33.3% | |
| 2 | 14 | 9.2% | 6 | 18.2% | 81 | 31.0% | 4 | 22.2% | |
| 3 | 20 | 13.1% | 11 | 33.3% | 78 | 39.9% | 15 | 23.8% | |
| 4 | 11 | 7.2% | 5 | 15.2% | 44 | 16.9% | 11 | 17.5% | |
| Fat cell fraction (%) | 50.46 | ±33.38 | 5.45 | ±14.64 | 18.27 | ±23.70 | 19.29 | ±26.66 | NBNC≠(AILD=CHB=CHC) |
| FIB4 | 1.596 | ±1.418 | 3.066 | ±3.156 | 2.172 | ±2.209 | 2.472 | ±2.015 | NBNC≠(AILD=CHB=CHC) |
| ARFI meanAB (m/s) | 1.328 | ±0.524 | 1.722 | ±0.508 | 1.425 | ±0.461 | 1.557 | ±0.660 | NBNC≠(AILD=CHC); CHB≠AILD |
PLT: Platelet, AILD: Autoimmune liver diseases, CHB: Chronic hepatitis B, CHC: chronic hepatitis C, AST: Aspartate aminotransferase, HCC: Hepatocellular carcinoma, ALT: Alanine aminotransferase, GGT: Gamma-glutamyl transpeptidase, INR: International normalization ratio, FIB4: Fibrosis-4 score, ARFI: Acoustic radiation force impulse, MeanAB: Mean of ARFI measured from location A and B, ALP: Alkaline phosphatase, BMI: Body mass index, SD: Standard deviation, NBNC: Non-B non-C